Bertis is a global leader in proteomics-based precision medicine,
one of the most promising next-generation medical technologies.

• By combining proteomics (the study of proteins) with bioinformatics, Bertis discovers biomarkers for cancer and major diseases, developing them into diagnostic and analytical solutions.

  

• Since its establishment in 2014,
  Bertis has accumulated over 10 years of expertise in protein mass spectrometry and built a team of leading experts in clinical research, technology development, and data analysis.